Targeting p53–MDM2 interaction by small-molecule inhibitors: learning from MDM2 inhibitors in clinical trials
2022 · Journal of Hematology & Oncology · 203 citations
https://doi.org/10.1186/s13045-022-01314-3
H
Haohao Zhu
Sinopec (China)(CN)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
138
Papers
1.5K
Citations
18
h-index
39
i10-index
Haohao Zhu is an academic researcher from Sinopec (China). The author has contributed to research in topics: Pharmacovigilance and Adverse Drug Reactions & Tryptophan and brain disorders & Schizophrenia research and treatment. The author has an h-index of 18, co-authored 118 publications.
ORCID: 0000-0003-2352-4854Papers by this author
worksRole and mechanism of ferroptosis in neurological diseases
2022 · Molecular Metabolism · 137 citations
https://doi.org/10.1016/j.molmet.2022.101502
Ischemic postconditioning protects the heart against ischemia–reperfusion injury via neuronal nitric oxide synthase in the sarcoplasmic reticulum and mitochondria
2016 · Cell Death and Disease · 42 citations
https://doi.org/10.1038/cddis.2016.108
The role of gut microbiota and metabolomic pathways in modulating the efficacy of SSRIs for major depressive disorder
2024 · Translational Psychiatry · 23 citations
https://doi.org/10.1038/s41398-024-03208-z
Causal relationship between sex <scp>hormone‐binding</scp> globulin and major depression: A Mendelian randomization study
2023 · Acta Psychiatrica Scandinavica · 15 citations
https://doi.org/10.1111/acps.13614
Exploring adverse events of Vilazodone: evidence from the FAERS database
2024 · BMC Psychiatry · 14 citations
https://doi.org/10.1186/s12888-024-05813-0
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat